HomeThemesTypesDBAbout
Showing: ◈ James Barlow×
|< <- -> : New Old Date A-Z Z-A Popular Page 1 (1-1)
UK approved fewer new drugs than EU and US in year after Brexit transition 14/07/2022
Fears extra expense and paperwork caused by Brexit will make Britain unattractive to global drugmakers.
https://www.theguardian.com/
news Association of the British Pharmaceutical Industry BioIndustry Association bureaucracy David Watson disruption EMA James Barlow medicine MHRA NICE research Steve Bates
|< <- -> : New Old Date A-Z Z-A Popular Page 1 (1-1)
BrexitDB.com
database and aggregator
Copyright of cited content as per its respective owners | Copyright (of the database) - BrexitDB.com